Investors
Information Disclosure
-
NEXT DAY DISCLOSURE RETURN2026.03.30
-
NEXT DAY DISCLOSURE RETURN2026.03.27
-
VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO RESTRICTED SHARE AWARD SCHEME2026.03.27
-
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 20252026.03.26
-
FINAL DIVIDEND FOR 20252026.03.26
-
CHANGE OF STOCK SHORT NAME IN ENGLISH AND COMPANY WEBSITE2026.03.26
-
VOLUNTARY ANNOUNCEMENT - UPGRADE TO AA IN MSCI ESG RATINGS2026.03.23
-
VOLUNTARY ANNOUNCEMENT - APPLICATION FOR CLINICAL TRIAL ON TRD221 "COMPLEMENT PROTEIN MODULATOR" APPROVED BY THE NMPA2026.03.17